Heart Rhythm Clinical and Research Solutions

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Heart Rhythm Clinical and Research Solutions sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 5 currently recruiting top decile by trial count

Heart Rhythm Clinical and Research Solutions: 9 sponsored US clinical trials, 5 recruiting.

Heart Rhythm Clinical and Research Solutions sponsors 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. The most-studied condition in this pipeline is Paroxysmal Atrial Fibrillation, with 2 trials.

Top-decile sponsor footprint

Heart Rhythm Clinical and Research Solutions ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Heart Rhythm Clinical and Research Solutions pipeline

5 recruiting of 9 indexed (56% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Paroxysmal Atrial Fibrillation (2 trials), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Heart Rhythm Clinical and Research Solutions: open-pipeline peers nationwide

Peers matched on 9 registered trials and 56% open enrollment, not the therapeutic-area sidebar.

Heart Rhythm Clinical and Research Solutions sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 81012141618 0%20%40%60% Total trials Recruiting share Heart Rhythm Clinical and Research Solutions4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyDisc MedicineJoseph TuscanoReplimuneMGH Institute of Health Professions
Heart Rhythm Clinical and Research Solutions sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Heart Rhythm Clinical and Research Solutions sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 56% open enrollment (± trial volume)

What to do with this Heart Rhythm Clinical and Research Solutions page

9 registered trials is a research-attention snapshot, not an endorsement of Heart Rhythm Clinical and Research Solutions or any single study.

  • 5 of Heart Rhythm Clinical and Research Solutions's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Paroxysmal Atrial Fibrillation is the condition Heart Rhythm Clinical and Research Solutions studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Paroxysmal Atrial Fibrillation trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Heart Rhythm Clinical and Research Solutions pipeline card: 9 registered trials from official public datasets.Report a data error.